Zura Bio Limited (ZURA)
NASDAQ: ZURA · Real-Time Price · USD
1.280
+0.040 (3.23%)
Mar 6, 2025, 4:00 PM EST - Market closed

Zura Bio Statistics

Total Valuation

Zura Bio has a market cap or net worth of $83.58 million. The enterprise value is -$107.26 million.

Market Cap 83.58M
Enterprise Value -107.26M

Important Dates

The next estimated earnings date is Wednesday, March 12, 2025, after market close.

Earnings Date Mar 12, 2025
Ex-Dividend Date n/a

Share Statistics

Zura Bio has 65.29 million shares outstanding. The number of shares has increased by 199.50% in one year.

Current Share Class 65.29M
Shares Outstanding 65.29M
Shares Change (YoY) +199.50%
Shares Change (QoQ) +16.53%
Owned by Insiders (%) 6.50%
Owned by Institutions (%) 49.23%
Float 37.28M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.53
P/TBV Ratio 0.53
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 10.36

Current Ratio 10.36
Quick Ratio 10.32
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -36.85% and return on invested capital (ROIC) is -24.51%.

Return on Equity (ROE) -36.85%
Return on Assets (ROA) -21.40%
Return on Invested Capital (ROIC) -24.51%
Return on Capital Employed (ROCE) -29.44%
Revenue Per Employee n/a
Profits Per Employee -$2.84M
Employee Count 15
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -63.32% in the last 52 weeks. The beta is 0.06, so Zura Bio's price volatility has been lower than the market average.

Beta (5Y) 0.06
52-Week Price Change -63.32%
50-Day Moving Average 1.79
200-Day Moving Average 3.33
Relative Strength Index (RSI) 39.09
Average Volume (20 Days) 266,178

Short Selling Information

The latest short interest is 5.13 million, so 7.85% of the outstanding shares have been sold short.

Short Interest 5.13M
Short Previous Month 4.88M
Short % of Shares Out 7.85%
Short % of Float 13.75%
Short Ratio (days to cover) 5.43

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -50.28M
Pretax Income -58.52M
Net Income -42.62M
EBITDA n/a
EBIT -50.28M
Earnings Per Share (EPS) -$0.66
Full Income Statement

Balance Sheet

The company has $188.22 million in cash and n/a in debt, giving a net cash position of $188.22 million or $2.88 per share.

Cash & Cash Equivalents 188.22M
Total Debt n/a
Net Cash 188.22M
Net Cash Per Share $2.88
Equity (Book Value) 170.83M
Book Value Per Share 2.34
Working Capital 170.73M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$21.31 million and capital expenditures -$30,000, giving a free cash flow of -$21.34 million.

Operating Cash Flow -21.31M
Capital Expenditures -30,000
Free Cash Flow -21.34M
FCF Per Share -$0.33
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Zura Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -199.50%
Shareholder Yield -199.50%
Earnings Yield -52.64%
FCF Yield -26.35%

Analyst Forecast

The average price target for Zura Bio is $15.80, which is 1,134.38% higher than the current price. The consensus rating is "Buy".

Price Target $15.80
Price Target Difference 1,134.38%
Analyst Consensus Buy
Analyst Count 6
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2